In previous studies [14,15], Corso G et al demonstrated that MSI-H GC had distinct clinicopathological features and frequently showed activation of PI3K/AKT pathway compared with MSS GC, which was similar to our findings (Table 1). This evidence concerns the gene AKT1 and gastric cancer.